(Q83178667)
Statements
Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma (English)
Dimitrios Pectasides
Dimitrios Bafaloukos
Dimosthenis Skarlos
Aristidis Polyzos
Dimosthenis Tsoutsos
George Fountzilas
Petros Panagiotou
George Kokkalis
Othon Papadopoulos
Ourania Castana
Stefanos Papadopoulos
Elias Stavrinidis
Georgia Vourli
John Ioannovich